Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein CBP2 (collagen-binding protein 2) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring CBP2 in said sample. Measurement of CBP2 can, e.g., be used in the early detection or diagnosis of colorectal cancer.

Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of the protein nicotinamide N-methyltransferase (NNMT) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring NNMT in said sample. Measurement of NNMT can, e.g., be used in the early detection or diagnosis of colorectal cancer.

Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein PSE3 (proteasome activator subunit 3) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring PSE3 in said sample. Measurement of PSE3 can, e.g., be used in the early detection or diagnosis of colorectal cancer.

Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein RLA-0 (60S acidic ribosomal protein P0) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring RLA-0 in said sample. Measurement of RLA-0 can, e.g., be used in the early detection or diagnosis of colorectal cancer.

Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein SPEE (sperrnidine synthase) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring SPEE in said sample. Measurement of SPEE can, e.g., be used in the early detection or diagnosis of colorectal cancer.

Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein PLST (T-plastin) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring PLST in said sample. Measurement of PLST can, e.g., be used in the early detection or diagnosis of colorectal cancer.

Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein PRN3/ILEU and/or unbound PRN3 in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring PRN3/ILEU and/or unbound PRN3 in said sample. Measurement of PRN3/ILEU and/or unbound PRN3 can, e.g., be used in the early detection or diagnosis of colorectal cancer.

Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein MASP in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring MASP in said sample. Measurement of MASP can, e.g., be used in the early detection or diagnosis of colorectal cancer.

Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of the protein nicotinamide N-methyltransferase (NNMT) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring NNMT in said sample. Measurement of NNMT can, e.g., be used in the early detection or diagnosis of colorectal cancer.

Abstract: The present invention concerns an antibody against a hepatitis G virus antigen as well as a fragment of this antibody. The invention additionally concerns hybridoma cell lines as well as a conjugate that contains this antibody or the antibody fragment coupled to a biological molecule. Finally the present invention concerns the use of the antibody for the diagnostic detection of hepatitis G virus.

Abstract: The ore which contains gold and at least one of the metals silver, copper, nickel, zinc or iron is calcined at temperatures in the range from 500.degree. to 900.degree. C. with the addition of oxygen-containing gas, thereby producing a metal-oxide-containing solids mixture and a SO.sub.2 -containing exhaust gas. The SO.sub.2 containing exhaust gas is brought in contact with aqueous solution, thereby producing a sulfite-containing solution. The solids mixture from the calcination is cooled to temperatures in the range from 50.degree. to 300.degree. C. and is stirred up with the sulfite-containing solution. Metal oxides are dissolved, and a sulfate-containing solution os formed. In a first separating zone, the sulfate-containing solution is separated from the solids, and either the solids are supplied to a gold leaching or the sulfate-containing solution is subjected to a further treatment for the separation of nonferrous metals.

Abstract: The ore which contains gold and/or silver and as accompanying metal at least iron is calcined at temperatures in the range from 500.degree. to 900.degree. C. with the addition of oxygen-containing gas. There is obtained a metal-oxide-containing solids mixture and a SO.sub.2 -containing exhaust gas. The solids mixture from the calcination is cooled, the temperature being reduced by at least 50.degree. C. The cooled solids mixture is added to a fluidized-bed reactor, and SO.sub.2 -containing exhaust gas is introduced into the fluidized-bed reactor. In the reactor, metal sulfate is produced in the solids mixture, so that at least 10% of the sulfur content are bound in the exhaust gas. Solids mixture containing metal sulfate is withdrawn from the fluidized-bed reactor, is stirred up with an aqueous acid solution, thereby dissolving metal sulfate. The remaining solids are supplied to a recovery of gold and/or silver.

Abstract: To effect a quasi-isothermal catalytic reaction of SO.sub.2 to SO.sub.3, a plurality of consecutive rows of banks of cooling tubes, are provided in the bed of shaped catalyst bodies in a contact reactor in such a manner that the banks of succeeding rows are staggered from the banks of the preceding rows. The distance between the cooling tubes in the banks is so selected that a penetration of entire catalyst bodies into the banks will virtually be prevented. The banks are so designed that the pressure drop of the gas in the banks is approximately the same as the pressure drop in the layer of catalyst between the bank. The distance between the banks is larger than the width of the banks.

Abstract: A process for the production of sulfuric acid from wet sulfur dioxide containing gases is disclosed. The sulfur dioxide containing gas is initially purified and cooled, then predried with dilute sulfuric acid, finally dried with concentrated sulfuric acid, converted to sulfur trioxide catalytically and, the sulfur trioxide is absorbed in sulfuric acid. Preliminary drying removes more water than needed to maintain the water balance in the following process steps. A portion of the dilute acid from the preliminary drying is concentrated prior to recycle to the preliminary drying step and another portion of the acid from the preliminary dryer is added to the sulfur trioxide absorber to adjust the water balance in the acid circulating between the final dryer and the sulfur trioxide absorber.

Abstract: Sulfuric acid is produced from sulfur trioxide-containing humid gases by a process wherein the sulfur trioxide-containing humid gases are directly cooled with aqueous sulfuric acid, sulfuric acid is condensed and the gas is cooled below dew point of the sulfuric acid, and the water not required to form sulfuric acid is discharged as water vapor with the end gases.

Abstract: Sulfur compounds oxidizable to form sulfuric acid and organic compounds oxidizable to CO.sub.2 and H.sub.2 O are removed from an exhaust gas of a contact-process plant for producing sulfuric acid by treating the exhaust gas with a scrubbing solution consisting of dilute sulfuric acid and peroxydisulfuric acid. The peroxydisulfuric acid is produced electrolytically from fresh dilute sulfuric acid and the resulting electrolyte is continuously introduced into the scrubbing acid cycle. The exhaust gas is treated in a vertical venturi with uniflow, i.e. codirectional flow of the gas and the scrubbing solution, and the gas is then passed through a horizontal venturi and subsequently upwardly through a packing layer.CROSS-REFERENCE TO RELATED APPLICATIONThe present Application is related to the commonly assigned copending application Ser. No. 308,849 filed Nov. 22, 1972 and entitled METHOD OF REMOVING GASEOUS IMPURITIES FROM WASTE GASES now abandoned.